Sabine Kolbe-Zitzmann
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 01, 2023
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 26, 2023
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.
Journal: Molecular cancer therapeutics
Published: January 18, 2023
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2021
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.
Journal: Journal of medicinal chemistry
Published: August 24, 2021
Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.
Journal: British journal of cancer
Published: April 14, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2021
DNA repair inhibitors sensitize cells differently to high and low LET radiation.
Journal: Scientific reports
Published: December 15, 2020
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: April 08, 2020
Radiobiological effects of the alpha emitter Ra-223 on tumor cells.
Journal: Scientific reports
Published: September 04, 2019
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2019
Last Updated: 09/26/2026